Sacituzumab

Modify Date: 2024-01-19 09:21:25

Sacituzumab Structure
Sacituzumab structure
Common Name Sacituzumab
CAS Number 1796566-95-4 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Sacituzumab


Trastuzumab is a humanized IgG1 monoclonal antibody for anti-trophoblast cell-surface antigen 2 (anti-Trop-2). Sacituzumab has the potential for metastatic triple-negative breast cancer research[1].

 Names

Name Sacituzumab

 Sacituzumab Biological Activity

Description Trastuzumab is a humanized IgG1 monoclonal antibody for anti-trophoblast cell-surface antigen 2 (anti-Trop-2). Sacituzumab has the potential for metastatic triple-negative breast cancer research[1].
Related Catalog
References

[1]. A Bardia, et al. Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer. Ann Oncol. 2021 Sep;32(9):1148-1156.

 Chemical & Physical Properties

No Any Chemical & Physical Properties
Top Suppliers:I want be here

Get all suppliers and price by the below link:

Sacituzumab suppliers

Sacituzumab price